Revaprazan Hydrochloride CAS 178307-42-1 Assay ≥99.0% API Factory High Tsabta
Sunan Chemical: Revaprazan Hydrochloride;Farashin HCL
Saukewa: 178307-42-1
API High Quality, Kasuwancin Kasuwanci
Sunan Sinadari | Revaprazan Hydrochloride |
Makamantu | Farashin HCL |
Lambar CAS | 178307-42-1 |
Lambar CAT | RF-API48 |
Matsayin Hannun jari | A Hannun jari, Ma'aunin Samfuran Har zuwa Daruruwan Kilogram |
Tsarin kwayoyin halitta | Saukewa: C22H24ClFN4 |
Nauyin Kwayoyin Halitta | 398.904 |
Alamar | Ruifu Chemical |
Abu | Ƙayyadaddun bayanai |
Bayyanar | Fari ko Kashe-White Crystalline Foda |
Solubility | Mai narkewa da yardar kaina a cikin chloroform, dichlormeth;Mai narkewa a cikin acetic acid;Dan kadan mai narkewa a cikin methanol, DMSO;Da kyar mai narkewa a cikin acetone, ACN;Kusan baya narkewa a cikin maganin 0.1mol/L NaOH.0.1mol/L HCL bayani. |
Ganewa | Yakamata a mayar da martani mai inganci λ max 271nm, 205nm IR |
Matsayin narkewa | 219.0 ~ 222.0 ℃ |
Tsara da Launi | Ya kamata ya zama bayyananne kuma mara launi a cikin dichlormeth |
Chloride | ≤8.93% |
Tsaftace Guda Daya | ≤0.10% |
Jimlar ƙazanta | ≤0.50% |
Asara akan bushewa | ≤0.50% |
Ragowa akan Ignition | ≤0.10% |
Sulfate | ≤20ppm |
Arsenic | ≤10ppm |
Karfe masu nauyi | ≤10ppm |
Assay | ≥99.0% |
Matsayin Gwaji | Matsayin Kasuwanci |
Amfani | Sinadarin Magunguna Mai Aiki (API) |
Kunshin: Bottle, Aluminum tsare jakar, Kwali drum, 25kg / Drum, ko bisa ga abokin ciniki ta bukata.
Yanayin Ajiya:Ajiye a cikin kwantena da aka rufe a wuri mai sanyi da bushe;Kare daga haske, danshi da kamuwa da kwari.
Shanghai Ruifu Chemical Co., Ltd. shine babban masana'anta kuma mai samar da Revaprazan Hydrochloride (CAS: 178307-42-1) tare da inganci mai inganci.Revaprazan Hydrochloride yana rage maganganun COX-2 kuma yana da mahimman ayyukan ayyukan anti-mai kumburi a cikin kamuwa da cutar H. pylori.Revaprazan Hydrochloride a cikin lura da duodenal miki, ciki miki da gastritis.
Revaprazan Hydrochloride (kuma aka sani da reversible proton pump inhibitors, potassium competitive acid blockers, p-CABs) wani sabon ƙarni ne na masu hana famfo mai jujjuyawar proton da kuma kawai masu hana masu hana famfo acid na potassium ko kuma masu adawa da famfo acid a cikin duniya.Kamfanin Yuhan na Koriya ta Kudu ya haɓaka kuma tare da haƙƙin mallakar fasaha, GLAxoSmithKline ya sami lasisin haɓakawa da tallace-tallace na duniya don maganin a wajen Koriya ta Kudu da Koriya ta Arewa.FDA ta Koriya ta Kudu ta amince da miyagun ƙwayoyi a cikin 2007 don magance cututtukan duodenal ulcers da gastritis.